Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure of Lipids03:38

Structure of Lipids

95.9K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
95.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

131
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
131
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

5.8K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.8K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

1.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

183
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
183
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

344
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peak myocardial work assessment to detect coronary ischemia during dobutamine stress echocardiography.

Frontiers in cardiovascular medicine·2025
Same author

Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.

Progress in cardiovascular diseases·2024
Same author

Estrogen and cardiovascular disease.

Progress in cardiovascular diseases·2024
Same author

Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes.

Journal of the American College of Cardiology·2023
Same author

Testosterone and cardiovascular health.

European heart journal·2023
Same author

Hormones and COVID-19.

Mayo Clinic proceedings·2023

Related Experiment Video

Updated: Nov 21, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.4K

An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health.

Andrew Elagizi1, Carl J Lavie1, Evan O'Keefe2

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA 70121, USA.

Nutrients
|January 15, 2021
PubMed
Summary
This summary is machine-generated.

Omega-3 fatty acids show potential cardiovascular benefits, with high-dose eicosapentaenoic acid (EPA) significantly reducing cardiovascular disease events. Optimal dosing and patient selection are key to realizing these benefits.

Keywords:
cardiovascular diseaseomega 3 indexomega 3 polyunsaturated fatty acid

More Related Videos

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.4K
NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
08:54

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

Published on: May 1, 2017

26.5K

Related Experiment Videos

Last Updated: Nov 21, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.4K
Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.4K
NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
08:54

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

Published on: May 1, 2017

26.5K

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Science
  • Pharmacology

Background:

  • Interest in omega-3 polyunsaturated fatty acids (Ω-3) for cardiovascular (CV) health dates back to the 1940s.
  • Early trials suggested reduced cardiovascular disease (CVD) risk, but subsequent studies yielded conflicting results.
  • Recent large trials in 2018 also presented discordant findings on Ω-3 therapy efficacy.

Purpose of the Study:

  • To review current evidence on Ω-3 fatty acids and CV health.
  • To explore reasons for discrepant results in Ω-3 research.
  • To address current recommendations and the role of Ω-3 blood levels.

Main Methods:

  • Review of existing scientific literature and clinical trials on Ω-3 fatty acids and cardiovascular outcomes.
  • Analysis of factors potentially influencing trial results, including dosage and patient treatment.
  • Discussion of Ω-3 index as a biomarker for assessing Ω-3 status.

Main Results:

  • A 2018 trial using high-dose (4 g/day) purified eicosapentaenoic acid (EPA) demonstrated a significant reduction in CVD events.
  • Conflicting results in other trials may be attributed to insufficient Ω-3 dosing (<1 g/day EPA and docosahexaenoic acid (DHA)) or concurrent aggressive medical therapies.
  • The Ω-3 index is highlighted as a critical concept for measuring Ω-3 levels.

Conclusions:

  • High-dose EPA may offer significant cardiovascular benefits.
  • Dosing and patient selection are crucial factors in Ω-3 therapy outcomes.
  • Further research and standardized measurement of Ω-3 levels are needed to clarify therapeutic recommendations.